Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v4-FR
Language English French
Date Updated 2018-06-15 2018-05-04
Drug Identification Number 02216973 02216973
Brand name REOPRO REOPRO
Common or Proper name Abciximab Abciximab
Company Name JANSSEN INC JANSSEN INC
Ingredients ABCIXIMAB ABCIXIMAB
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1x5 1x5
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-05-04 2018-05-04
Actual start date
Estimated end date 2019-12-31 2019-12-31
Actual end date 2018-06-14
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments